Novalis Biotech
Investor profile
Venture capital
Novalis Biotech has backed 3 European tech companies across 4 funding rounds between 2022 and 2026, joining rounds totalling €23M. Most active in Healthtech. Data as of 4 Nov 2026.
Deals
4
distinct rounds
Companies
3
backed
Active span
2022–2026
5 yrs
Total round €
€23M
sum of rounds joined
Deals by year
distinct rounds / yearNovalis Biotech — deals by year — interactive chart.
Data table
| Novalis Biotech — deals by year | |
|---|---|
| 2022 | 1 |
| 2024 | 1 |
| 2026 | 2 |
Top sectors
by dealsNovalis Biotech — top sectors — interactive chart.
Data table
| Novalis Biotech — top sectors | |
|---|---|
| Healthtech | 4 |
Stages
by dealsNovalis Biotech — stages — interactive chart.
Data table
| Novalis Biotech — stages | |
|---|---|
| Series A | 3 |
| Seed | 1 |
Countries
by dealsNovalis Biotech — countries — interactive chart.
Data table
| Novalis Biotech — countries | |
|---|---|
| Germany | 2 |
| Netherlands | 1 |
| Switzerland | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- bm-t Beteiligungsmanagement Thüringen GmbH2
- High-Tech Gründerfonds (HTGF)2
- Technologiegründerfonds Sachsen (TGFS)2
- Demcon Investment1
- Dutch Government1
- Genku Ventures1
- i&i Biotech Fund1
- OCCIDENT1
- Oost NL1
- Ostwerk GmbH1
- Takeda Ventures1
- TUDAG TU1
- TUDAG TU Dresden AG1
- Unternehmen Saxonia Systems Holding1
- Zürcher Kantonalbank1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Enzyre | Netherlands | 1 | €12M |
| Altavo | Germany | 2 | €8.0M |
| Alithea Genomics | Switzerland | 1 | €3.3M |